Polarean Imaging Plc (POLX.L) Announced that it has completed the installation of its latest research unit order for a 9820 Xenon Polariser system at the University of Kansas Medical Center. Further, KU Medical Center is a major research and teaching hospital and this polariser will form the cornerstone of a new hyperpolarised 129Xe imaging research programme. #POLX
RNS Number: 3594 Z Polarean Imaging PLC 18 September 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical-imaging technology company, with a proprietary investigational drug-device combination diagnostic for magnetic resonance imaging, announces that it has completed the installation of its latest research unit order for a 9820 Xenon Polariser...
Polarean Imaging plc, the medical‑ imaging technology company, with a proprietary drug‑ device combination diagnostic for the magnetic resonance imaging market, announces a number of presentations highlighting the use of hyperpolarized Xenon 129 will be made by leading academic researchers at the upcoming American Thoracic Society virtual conference...
Polarean Imaging plc, the medical‑ imaging technology company, with a proprietary drug‑ device combination diagnostic for the magnetic resonance imaging market, announces a number of presentations highlighting the use of hyperpolarized Xenon 129 will be made by leading academic researchers at the upcoming American Thoracic Society virtual conference...
RNS Number: 5297 U Polarean Imaging PLC 30 July 2020 Polarean Imaging plc. Scientific presentations on hyperpolarized 129 Xenon at upcoming medical meetings. Additionally, Talissa Altes, MD, Professor and Chair of Radiology at the University of Missouri will be delivering a presentation on Xenon lung magnetic resonance imaging during the Lung/Thoracic MRI...
RNS Number: 8546 S Polarean Imaging PLC 13 July 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical- imaging technology company, with a proprietary drug- device combination product for the magnetic resonance imaging market, announces that at the AGM held earlier today, all resolutions were duly passed. RNS is approved by the Financial Conduct Authority...
·Third trial site added at University of Cincinnati, in addition to Duke University and the University of Virginia, to improve enrolment rates for its two pivotal Phase III Clinical Trials. ·Sale and Installation of three new Polarean 9820 Xenon Polariser systems to the University of British Columbia, The Hospital for Sick Children in Toronto and the...
RNS Number: 4443 O Polarean Imaging PLC 01 June 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical- imaging technology company, with a proprietary drug- device combination product for the magnetic resonance imaging market, announces that that it has received notification from a warrant holder to exercise warrants representing 534,400 ordinary...
RNS Number: 4439 O Polarean Imaging PLC 01 June 2020 Polarean Imaging Plc. Bracco recently acquired a 7.6% interest in the ordinary share capital of Polarean as part of the Company's £8.4 m fundraise, which was first announced on 13 March 2020. There, he led the group's transformation and helped to accelerate growth through a series of transactions worth in...
RNS Number: 4920 M Polarean Imaging PLC 11 May 2020. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 4910 M Polarean Imaging PLC 11 May 2020. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5159 L Polarean Imaging PLC 30 April 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical- imaging technology company, with a proprietary drug- device combination product for the magnetic resonance imaging market, announces that the total number of shares in issue and total voting rights as at the date of this announcement is 161,295,607...
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    161.83M

Featured Media

Company Profile

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments with special focus on pulmonary imaging using hyperpolarized gas MRI. Current product offerings of Polarean include xenon-129 and helium-3 polarizers, polarization measurement stations and upgrade kits for existing polarizers.

Classification

Market Indices-
Watchlist